Spotlight
Memorials
Classifieds
Families First
VCAs
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Weather
87 NC counties and 1 VA county are under alert, including Wake, Durham, Orange, Nash, and Franklin counties.
Just In
Duke wins ACC: Blue Devils win first ACC football title in over 60 years with 27-20 upset win over No. 17 Cavaliers
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about renal cell carcinoma
Recent news which mentions renal cell carcinoma
Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer
February 17, 2022
Tickers
ALKS
Tags
Biotech
General
Benzinga
From
Benzinga
Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial
February 15, 2022
Tickers
BMY
EXEL
Tags
Benzinga
renal cell carcinoma
EXEL
From
Benzinga
Aveo Says Tivozanib Patients Up To 5X More Likely To Experience Long-Term PFS Vs. Nexavar In Kidney Cancer
February 15, 2022
Tickers
AVEO
BAYRY
Tags
General
AVEO
Phase 3 Trial
From
Benzinga
Merck's Keytruda Wins European Approval For Post-Surgery Kidney Cancer
January 27, 2022
Tickers
MRK
Tags
Market News
Briefs
General
From
Benzinga
EMA's CHMP Backs Approval For Merck's Keytruda In Adjuvant Setting For Kidney Cancer
December 17, 2021
Tickers
MRK
Tags
European Medicines Agency
General
Biotech
From
Benzinga
Bristol Myers Touts 5-Year Kidney Cancer Data For Opdivo-Yervoy Combo Therapy
September 16, 2021
Tickers
BMY
PFE
Tags
Health Care
News
Market News
From
Benzinga
Exelixis' Cabometyx Combo Trial Shows Benefit In Kidney Cancer Regardless Of Prior Surgery
September 16, 2021
Tickers
BMY
EXEL
PFE
Tags
Briefs
Market News
ESMO21
From
Benzinga
Exelixis - Takeda's Cabometyx Scores Approval In Japan For Kidney Cancer
August 26, 2021
Tickers
BMY
EXEL
TAK
TKPHF
Tags
renal cell carcinoma
Benzinga
TKPHF
From
Benzinga
Merck's Belzutifan Wins FDA Approval As First Drug For Rare VHL Tumors
August 16, 2021
Tickers
MRK
Tags
tumors
MRK
cancer
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.